EnPlusOne Biosciences

About EnPlusOne Biosciences

EnPlusOne Bio focuses on innovative solutions for emerging RNA therapeutics, harnessing the power and flexibility of enzymes to deliver RNA to the world.

Products & Services

RNA Therapeutics Solutions:Innovative solutions leveraging enzymes for the development and delivery of RNA therapeutics.

Specialties

RNA Therapeutics Enzyme Technology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Equity Financing T: - FT: Equity Financing	A: 10000000 MR: - FA: approximately $10 million FAN: 10000000	D: 2025-02-19 FD: 2025-02-19	2 investors
2	RT: Undisclosed T: - FT: Undisclosed	A: 10000000 MR: - FA: approximately $10 million FAN: 10000000	D: 2025-02-19 FD: 2025-02-19	2 investors
3	RT: Financing Round T: - FT: Financing Round	A: 10000000 MR: - FA: approximately $10 million FAN: 10000000	D: 2025-02-19 FD: 2025-02-19	2 investors

Equity Financing Latest

2025-02-19

$10.0M

2 investors (Pro only)

Undisclosed 2025-02-19

$10.0M

Financing Round 2025-02-19

$10.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Jonathan Rittichier, PhD

Co-founder, CSO

D

Dan Ahlstedt, MBA

Co-founder, COO

B

Bob Flynn

Director of Engineering

E

Ella Meyer

Lead of RNA Synthesis

D

Dominic Rainone, MS

Scientist – Chemistry

J

Jenn DeFreitas

Associate Scientist I

View 19 more team members with Pro

Unlock Full Team Directory

Recent News